Literature DB >> 35879930

Openness toward the use of telemedicine among medical students in Romania: A cross-sectional study.

Stefana Cretu1,2,3, Ana-Maria Gorzko1, Carmen Maria Salavastru1,3.   

Abstract

Entities:  

Year:  2022        PMID: 35879930      PMCID: PMC9307467          DOI: 10.1016/j.jdin.2022.06.011

Source DB:  PubMed          Journal:  JAAD Int        ISSN: 2666-3287


× No keyword cloud information.
To the Editor: Telemedicine offered access to medical care throughout the COVID-19 pandemic, when in-person visits were restricted., Between May 20, 2021, and May 30, 2021, we performed a cross-sectional, online survey, using Google Forms, distributed among medical students attending the medical school at our university, regardless of the study year. This study was approved by the university’s ethical committee. Informed consent was obtained from participants. Answers were anonymous. Views assessing adequacy of dermatology for telemedicine were recorded as an ordinal 1- to 5-point scale, where 1 was attributed to “strongly disagree” and 5 to “strongly agree.” Some of the survey questions were previously used in a study conducted by the same lead investigator (SC). The aim of this study was to evaluate attitudes, beliefs, and behaviors in the study population since the beginning of the COVID-19 pandemic up to the moment of response to this questionnaire, an average period of 14 months. Microsoft Excel 16 (Microsoft) and IBM SPSS, version 28 (IBM), were used for data analysis. We recorded 200 answers; 33 incomplete answers were excluded. The remaining 167 were analyzed. The mean age was 23.86 ± 4.589 years, 77.8% (n = 130) were female, 96.4% (n = 161) lived in urban settings, and 30.5% (n = 51) considered specializing in dermatology. Data regarding the use of telemedicine and teledermatology are presented. When questioned whether during the COVID-19 pandemic they or someone close needed medical assistance, 56.9% (n = 95) agreed, 41.9% (n = 70) denied, and 1.2% (n = 2) were unsure. Regarding whether they used telemedicine to receive medical care, 78.4% (n = 131) denied, 19.8% (n = 33) agreed, and 1.8% (n = 3) were unsure. Regarding their opinion toward teledermatology consultation, 56.3% (n = 94) of 167 participants chose that they did not use this service. The results for the remaining 73 are detailed in Table I.
Table I

Reported perception, expectations regarding teledermatology and reasons for choosing it

N (%)
Total number of complete questionnaires167
Did you or someone close to you use telemedicine services to receive medical care?
Yes33 (19.8%)
No31 (78.4%)
Do not know3 (1.8%)
What is your opinion on teledermatology consultations?
Users of teledermatology expressing their belief28Nonusers of teledermatology expressing their belief45
Very displeased1 (3.6%)0
Displeased01 (2.2%)
Neutral6 (21.4%)30 (66.7%)
Pleased16 (57.1%)12 (26.7%)
Very pleased5 (17.9%)2 (4.4%)
How likely is it for you to choose telemedicine for a dermatologic condition rather than physical consultation?
Users of teledermatology33Nonusers of teledermatology134
Absolutely not00
Unlikely7 (21.2%)61 (45.5%)
Possible14 (42.4%)55 (41.0%)
Very likely9 (27.3%)15 (11.2%)
Absolutely yes3 (9.1%)3 (2.2%)
What are your expectations regarding telemedicine services?
Users of teledermatology33Nonusers of teledermatology134
Efficient patient-physician communication28 (84.8%)105 (78.4%)
Prompt diagnosis and treatment21 (63.6%)64 (47.8%)
Short waiting time to consultation28 (84.8%)87 (64.9%)
The physician's increased attention to patient history23 (69.7%)81 (60.4%)
Receiving treatment immediately after consult, without a further visit being required11 (33.3%)27 (20.1%)
Which would be the reasons for using teledermatology instead of physical consultation?
Users of teledermatology33Nonusers of teledermatology134
Easy to get an appointment25 (75.8%)76 (56.7%)
As a way to prevent infection with the new coronavirus12 (36.4%)40 (29.9%)
The way in which the appointment takes place14 (42.4%)40 (29.9%)
As a way to avoid hospital anxiety or that caused by a physical consultation5 (15.2%)20 (14.9%)
For emergency situations, when in areas with unavailable medical services27 (81.8%)100 (74.6%)
What type of consultation would you prefer for teledermatology?
Users of teledermatology33Nonusers of teledermatology134
Live, real-time consultation5 (15.2%)44 (32.8%)
Store-and-forward consultation (a photo of the lesions is sent to a certain platform and afterward you wait for the result interpretation, followed by diagnosis and maybe treatment)7 (21.2%)12 (9.0%)
A combination of both of the above21 (63.6%)78 (58.2%)
Reported perception, expectations regarding teledermatology and reasons for choosing it Regarding teledermatology consultation types, from the 33 participants who had actually used teledermatology, 15.2% (n = 5) preferred real-time consultations, 21.2% (n = 7), store and forward, and 63.6% (n = 21), a combined approach. When questioned about the future use of teledermatology, 40.1% (n = 67) agreed, 34.7% (n = 58) were undecided, and 25.1% (n = 42) disagreed. From the 167 respondents, none fully excluded telemedicine over physical consultation for a dermatologic condition. Detailed analysis is presented in Table I. Medical students are the future health care providers. They experienced this pandemic from a dual perspective, for first, the person involved in patient care and for second, the young adult in need to adapt to a new lifestyle with different rules and many restrictions. As future doctors involved in patient triage and management, students’ perspective on the adequacy of dermatology for telemedicine compared to other specialties is important. Most considered it adequate, as 84.4% (n = 141) scored 3 or above. Acne and atopic dermatitis were considered most suited for management through teledermatology. Data are shown in Table II.
Table II

Reported adequacy of dermatology for telemedicine and conditions considered suitable for management through teledermatology

Do you consider that dermatology is better suited for telemedicine compared to other specialties?
Total number of complete questionnaires N = 167N (%)
1 Strongly disagree3 (1.73)
223 (13.29)
351 (29.47)
458 (33.52)
5 Strongly agree32 (18.49)
For which conditions would you choose teledermatology?
Total number of complete questionnaires N = 167N (%)
Acne136 (81.4)
Atopic dermatitis98 (58.7)
Psoriasis47 (28.1)
Atypical nevi37 (22.2)
Bullous diseases21 (12.6)
Seborrheic dermatitis2 (1.2)
Viral warts1 (0.6)
Impetigo1 (0.6)
Skin care1 (0.6)
Nail conditions2 (1.2)
Tinea corporis1 (0.6)
Reported adequacy of dermatology for telemedicine and conditions considered suitable for management through teledermatology Without replacing physical consultation, telemedicine has shown great promise in times of epidemiological crisis. In some countries, it has become part of the training curriculum. Our study found a moderate-to-high acceptability of telemedicine among Romanian medical students, many reporting that adequacy of dermatology for this approach is above that of other specialties.

Conflicts of interest

SC and AMG report no conflicts of interest. CMS declares the following, not related to the work: royalties from Springer Nature, consulting fees from Vichy International, and support for attending meetings from Leo Pharma.
  3 in total

1.  Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: A new occupational acne type?

Authors:  S Cretu; M Dascalu; S R Georgescu; C M Salavastru
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-09-30       Impact factor: 9.228

2.  Teledermatology in Times of COVID-19 Confinement: Comparing Patients' and Physicians' Satisfaction by the Standardized Brest Teledermatology Questionnaire.

Authors:  Joachim W Fluhr; Annie Gueguen; Delphine Legoupil; Emilie Brenaut; Claire Abasq; Helena Araújo; Laurent Misery
Journal:  Dermatology       Date:  2021-02-10       Impact factor: 5.366

3.  Intradisciplinary team meeting for teledermatology: an aid to improving clinician confidence.

Authors:  S Paget; S Zaman; N P Patel
Journal:  Clin Exp Dermatol       Date:  2021-08-26       Impact factor: 3.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.